TLP Group LLC increased its holdings in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 590.2% in the first quarter, HoldingsChannel reports. The institutional investor owned 33,128 shares of the financial services provider’s stock after purchasing an additional 28,328 shares during the quarter. iShares NASDAQ Biotechnology Index comprises about 2.4% of TLP Group LLC’s portfolio, making the stock its 4th biggest holding. TLP Group LLC’s holdings in iShares NASDAQ Biotechnology Index were worth $3,536,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of IBB. Quadrant Capital Group LLC bought a new position in iShares NASDAQ Biotechnology Index in the 1st quarter worth approximately $111,000. Bedel Financial Consulting Inc. bought a new position in iShares NASDAQ Biotechnology Index in the 1st quarter worth approximately $119,000. Edge Advisors LLC grew its holdings in iShares NASDAQ Biotechnology Index by 200.0% in the 4th quarter. Edge Advisors LLC now owns 1,305 shares of the financial services provider’s stock worth $139,000 after buying an additional 870 shares in the last quarter. All Terrain Financial Advisors LLC bought a new position in iShares NASDAQ Biotechnology Index in the 4th quarter worth approximately $140,000. Finally, Pittenger & Anderson Inc. grew its holdings in iShares NASDAQ Biotechnology Index by 188.0% in the 4th quarter. Pittenger & Anderson Inc. now owns 1,440 shares of the financial services provider’s stock worth $154,000 after buying an additional 940 shares in the last quarter. 60.10% of the stock is owned by institutional investors and hedge funds.

iShares NASDAQ Biotechnology Index traded up $0.12, reaching $110.61, on Thursday, MarketBeat.com reports. The company’s stock had a trading volume of 13,925 shares, compared to its average volume of 2,821,399. iShares NASDAQ Biotechnology Index has a 52 week low of $96.84 and a 52 week high of $119.30.

About iShares NASDAQ Biotechnology Index

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares NASDAQ Biotechnology Index (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares NASDAQ Biotechnology Index (NASDAQ:IBB)

Receive News & Ratings for iShares NASDAQ Biotechnology Index Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares NASDAQ Biotechnology Index and related companies with MarketBeat.com's FREE daily email newsletter.